SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Aranow, C
Right arrow Articles by Ginzler, E M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aranow, C
Right arrow Articles by Ginzler, E M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Reviews

Epidemiology of cardiovascular disease in systemic lupus erythematosus

C Aranow

SUNY Health Science Center at Brooklyn, 450 Clarkson Avenue, Box 42, Brooklyn, NY, USA

E M Ginzler

SUNY Health Science Center at Brooklyn, 450 Clarkson Avenue, Box 42, Brooklyn, NY 11203, USA Lupus

Awareness of the impact of cardiovascular disease on the late morbidity and mortality in patients with Systemic Lupus Erythematosus (SLE) is increasing. Clinical events secondary to accelerated atherosclerosis have been documented in lupus cohorts across the globe. We review the history and epidemiology of cardiovascular disease in patients with SLE.

Key Words: systemic lupus erythematosus • coronary artery disease • atherosclerosis

Lupus, Vol. 9, No. 3, 166-169 (2000)
DOI: 10.1191/096120300678828208


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
LupusHome page
N. Braun, N. Wade, E. Wakeland, and A. Major
Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr-/- mice
Lupus, December 1, 2008; 17(12): 1070 - 1078.
[Abstract] [PDF]


Home page
LupusHome page
E Matsuura and L. Lopez
Autoimmune-mediated atherothrombosis
Lupus, October 1, 2008; 17(10): 879 - 888.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
S. Mathieu, H. Joly, G. Baron, A. Tournadre, J.-J. Dubost, J.-M. Ristori, J.-R. Lusson, and M. Soubrier
Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease
Rheumatology, August 1, 2008; 47(8): 1203 - 1207.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
G. A. Ferreira, T. P. Navarro, R. W. Telles, L. E. C. Andrade, and E. I. Sato
Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial
Rheumatology, October 1, 2007; 46(10): 1560 - 1565.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
O. Nived, M. Andersson, M. Lindgren, P. Malcus-Johnsson, A. Nihlberg, K. Nived, G. Reimer-Rasmusson, G. Sturfelt, C. Stahl-Hallengren, and A.A. Bengtsson
Adherence with advice and prescriptions in SLE is mostly good, but better follow up is needed: A study with a questionnaire
Lupus, September 1, 2007; 16(9): 701 - 706.
[Abstract] [PDF]


Home page
LupusHome page
E Matsuura, K Kobayashi, B. Hurley, and L. Lopez
Atherogenic Oxidized Low-Density Lipoprotein/{beta}2-Glycoprotein I (oxLDL/{beta}2GPI) Complexes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Lupus, July 1, 2006; 15(7): 478 - 483.
[Abstract] [PDF]


Home page
LupusHome page
L R Lopez, M Salazar-Paramo, C Palafox-Sanchez, B L Hurley, E Matsuura, and I Garcia-De La Torre
Oxidized low-density lipoprotein and {beta}2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis
Lupus, February 1, 2006; 15(2): 80 - 86.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
C. Gorman and D. Isenberg
Atherosclerosis and lupus
Rheumatology, August 1, 2004; 43(8): 943 - 945.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
A Theodoridou, L Bento, D P D'Cruz, M A Khamashta, and G R V Hughes
Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study
Ann Rheum Dis, December 1, 2003; 62(12): 1199 - 1203.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
E M C Sella, E I Sato, W A Leite, J A O. Filho, and A Barbieri
Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus
Ann Rheum Dis, November 1, 2003; 62(11): 1066 - 1070.
[Abstract] [Full Text] [PDF]



Advertisement